

| Sep.16 (Wed) | Sep.17 (Thur) | Sep.18 (Fri) | |
|---|---|---|---|
| Rm. 401 |
Opening Ceremony & Plenary Session 10:00~12:30 |
![]() |
![]() |
| Rm. 310 |
BioIndustry in UK & Korea Track 1 |
BioIndustry in UK & Korea Track 1 |
u~Health Track 12 |
|
Microfluidics System 14:00~16:00Session1 |
Stem Cell and Biologics 10:00~12:00Session3 |
Policies and Vision 10:00~12:00Session1 |
|
High Throughput Analysis for Diagnosis and Drug Discovery 16:20~18:20Session2 |
To be announced soon |
Technology and Standardization 13:00~15:00Session2 |
|
|
Business Models 15:20~17:20Session3 |
|||
| Rm. 311 |
Issues to Address in Life Science BD & Funding Track 2 |
Regenerative Medicine Track 8 |
Recent Trends on Biochip Technology Track 13 |
|
Update on Changing Trends in Venture Investments 14:00~16:00Session1 |
Recent Advances of Stem Cell 10:00~12:00Session1 |
Recent Progress in Protein and DNA Chips 10:00~12:00Session1 |
|
|
Critical Issues for Successful IR of Life Science Venture Companies 16:20~18:20Session2 |
Global Development Trends for Cell Therapy 13:00~15:00Session2 |
Nano and Biomedical Sensor Technologies 13:00~15:00Session2 |
|
|
Recent Advances of Tissue Egnineering 15:20~17:20Session3 |
Microfluidic Chips for Cells 15:20~17:20Session3 |
||
| Rm. 320 |
Technology Transfer and Licensing Track 3 |
Technology Transfer and Licensing Track 3 |
Clinical Drug Development Track 14 |
|
Building and Enforcing IP Value in Korea 14:00~16:00Session1 |
Supporting Activities for Technology Commercialization 10:00~12:00Session3 |
Early Phase Product Development: Helping Korean Companies to Access Western Markets 10:00~12:00Session1 |
|
|
The Journey from Discovery to the Market in the Life Sciences 16:20~18:20Session2 |
Supporting Activities for Technology Commercialization 13:00~15:00Session3 |
New Tools for Early Phase Clinical Drug Development 13:00~15:00Session2 |
|
|
Strategies for Successful Development of Biopharmaceuticals 15:20~17:20Session3 |
|||
| Rm. 321 |
Traditional Medicine Track 4 ~ Special Track |
Pharmaceutical Strategy for Incrementally Modified Drug Track 9 |
Bioactive Medical Implants Track 15 |
|
Recent Trends of R&D for Traditional Medicine in East-Asia 14:00-16:10Session1 |
Efficient Drug Delivery for IMD Strategies 10:00~12:00Session1 |
Biocompatible Implants in Medicine 10:00~12:00Session1 |
|
|
Recent Policy Trends of Traditional Medicine in East-Asia 16:30-18:15Session2 |
IMD Strategies for Biopharmaceuticals 13:00~15:00Session3 |
Cardiovascular Implants 13:00~15:00Session2 |
|
|
Advanced IMD Technologies for Next Generations 15:20~17:20Session3 |
Skeletal (Spinal, Orthopedic, and Dental) Implants 15:20~17:20Session3 |
||
| Rm. 330 |
Korea~Scotland Joint Symposium Track 5 ~ Special Track |
Strategy for Overseas Generic Marketing Track 10 |
Regulatory and GMP Compliance Track 16 |
| To be announced soon |
Innovative and Specific Strategy for the Participation of Korean Generic Industry for the World~market 10:00~12:00Session1 |
Updated Regulatory Issues for Biologicals 10:00~12:00Session1 |
|
|
Market Analysis and Measures for Korean Generic Drug Export to the World Market 13:00~15:00Session2 |
GMP Facility Design and Operation 13:00-15:00Session2 |
||
|
Generic Drug Patent Strategy for International Marketing 15:20~17:20Session3 |
QC/QA 15:20-17:20Session3 |
||
| Hall E1 & E2 |
Recent Advances of Stem Cell Differentiation Track 6 |
Therapeutic Antibody Track 11 |
Vaccine Track 17 |
|
Cell Differentiation from Human ES Cells 14:00~16:00Session1 |
Therapeutic Antibody 1 10:00~12:00Session1 |
Vaccine Industry in Asia 10:00~12:30Session1 |
|
|
Derivation of Tissue Specific Stem Cell 16:20~17:50Session2 |
Therapeutic Antibody 2 13:00~15:30Session2 |
Prospective Vaccine R&D 13:30~16:00Session2 |
|
|
Therapeutic Antibody 3 15:50~17:50Session3 |
|||
| Rm. 304 |
Next-generation Sequencing Track 18 |
||
|
Application of Next-generation Sequencing to Personal Genomics 10:00~12:00Session1 |
|||
|
The Present of 13:00~15:00Session2 |
|||
|
Introduction of Next-generation Sequencing Technology to Personal Medcine 15:20~17:20Session3 |
|||
| Rm. 402 |
APEC Harmonization Center Workshop Track 7 ~ Special Track |
APEC Harmonization Center Workshop Track 7 ~ Special Track |
Botanical New Drug Discovery and Development Track 19 |
| To be announced soon | To be announced soon |
Development of Botanical New Drug 10:00~12:00Session1 |
|
|
Regulation of Botanical Products 13:00~15:00Session2 |
|||
|
Global Market of Botanical Products 15:20~17:20Session3 |
|||
